Neurovascular mechanisms of Alzheimer's neurodegeneration
- PMID: 15808355
- DOI: 10.1016/j.tins.2005.02.001
Neurovascular mechanisms of Alzheimer's neurodegeneration
Abstract
In contrast to traditional neuroncentric views of Alzheimer's disease (AD), recent findings indicate that neurovascular dysfunction contributes to cognitive decline and neurodegeneration in AD. Here, I propose the neurovascular hypothesis of AD, suggesting that faulty clearance of amyloid beta peptide (A beta) across the blood-brain barrier (BBB), aberrant angiogenesis and senescence of the cerebrovascular system could initiate neurovascular uncoupling, vessel regression, brain hypoperfusion and neurovascular inflammation. Ultimately, this would lead to BBB compromise, to chemical imbalance in the neuronal environment and to synaptic and neuronal dysfunction, injury and loss. Based on the neurovascular hypothesis, I suggest an array of new potential therapeutic approaches that could be developed for AD, to enhance A beta clearance and neurovascular repair, and to protect the neurovascular unit from divergent inducers of injury and apoptosis.
Similar articles
-
Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease.Curr Alzheimer Res. 2007 Apr;4(2):191-7. doi: 10.2174/156720507780362245. Curr Alzheimer Res. 2007. PMID: 17430246 Review.
-
Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.Acta Neuropathol. 2009 Jul;118(1):103-13. doi: 10.1007/s00401-009-0522-3. Epub 2009 Mar 25. Acta Neuropathol. 2009. PMID: 19319544 Free PMC article. Review.
-
Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease.Cold Spring Harb Perspect Med. 2012 Oct 1;2(10):a011452. doi: 10.1101/cshperspect.a011452. Cold Spring Harb Perspect Med. 2012. PMID: 23028132 Free PMC article. Review.
-
Neurovascular defects and faulty amyloid-β vascular clearance in Alzheimer's disease.J Alzheimers Dis. 2013;33 Suppl 1(0 1):S87-100. doi: 10.3233/JAD-2012-129037. J Alzheimers Dis. 2013. PMID: 22751174 Free PMC article. Review.
-
HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer's disease.J Neuroinflammation. 2016 Aug 24;13(1):194. doi: 10.1186/s12974-016-0670-z. J Neuroinflammation. 2016. PMID: 27553758 Free PMC article.
Cited by
-
Current Advancement of Immunomodulatory Drugs as Potential Pharmacotherapies for Autoimmunity Based Neurological Diseases.Pharmaceuticals (Basel). 2022 Aug 29;15(9):1077. doi: 10.3390/ph15091077. Pharmaceuticals (Basel). 2022. PMID: 36145298 Free PMC article. Review.
-
Neuroinflammation: a common pathway in CNS diseases as mediated at the blood-brain barrier.Neuroimmunomodulation. 2012;19(2):121-30. doi: 10.1159/000330247. Epub 2012 Jan 11. Neuroimmunomodulation. 2012. PMID: 22248728 Free PMC article. Review.
-
Angiotensin II-inhibition: effect on Alzheimer's pathology in the aged triple transgenic mouse.Am J Transl Res. 2012;4(2):151-64. Epub 2012 Apr 12. Am J Transl Res. 2012. PMID: 22611468 Free PMC article.
-
Neuroglia in cognitive reserve.Mol Psychiatry. 2024 Dec;29(12):3962-3967. doi: 10.1038/s41380-024-02644-z. Epub 2024 Jul 2. Mol Psychiatry. 2024. PMID: 38956370 Free PMC article. Review.
-
HP35 Protein in the Mesopore of MIL-101(Cr) MOF: A Model to Study Cotranslocational Unfolding.ACS Omega. 2024 Jul 3;9(28):31185-31194. doi: 10.1021/acsomega.4c05452. eCollection 2024 Jul 16. ACS Omega. 2024. PMID: 39035967 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical